We performed a secondary transplantation and observed a significant reduction of leukemia load in the peripheral blood of secondary recipient mice transplanted with BM from MMP-9 inhibitor-treated primary B-ALL mice compared with controls (P = 0.03, Fig. 6d). This evidence concerns the gene MMP9 and leukemia.